Edition:
United States

Immune Pharmaceuticals Inc (IMNP.OQ)

IMNP.OQ on NASDAQ Stock Exchange Capital Market

0.79USD
10:04am EST
Change (% chg)

$0.01 (+1.92%)
Prev Close
$0.77
Open
$0.78
Day's High
$0.79
Day's Low
$0.78
Volume
2,293
Avg. Vol
157,152
52-wk High
$5.02
52-wk Low
$0.76

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.534
Jun '17 0.00 -0.500
Mar '17 0.00 -0.427
FY 2016 Dec '16 0.00 -1.538
Sep '16 0.00 -3.139
Jun '16 0.00 -2.659
Mar '16 0.00 -3.486
FY 2015 Dec '15 0.00 -5.273
Sep '15 0.00 -6.951
Jun '15 0.00 -2.371
Mar '15 0.00 -4.319
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.07 35.50
P/E High - Last 5 Yrs. -- 40.71 45.22
P/E Low - Last 5 Yrs. -- 23.60 24.21
Beta 2.05 0.92 0.91
Price to Sales (TTM) -- 3.92 5.89
Price to Book (MRQ) 18.50 4.84 5.66
Price to Tangible Book (MRQ) -- 5.71 7.25
Price to Cash Flow (TTM) -- 22.98 24.38
% Owned Institutions 2.01 0.87 1.41

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.49
Dividend Yield - 5 Year Avg -- 2.17 2.05
Dividend 5 Year Growth Rate -- 4.29 5.25
Payout Ratio(TTM) -- 47.46 46.15

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 6.31 6.81
Sales (TTM) vs TTM 1 Yr. Ago -- 5.12 5.59
Sales - 5 Yr. Growth Rate -- 9.98 10.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 82.98 7.17 7.98
EPS (TTM) vs TTM 1 Yr. Ago 79.40 -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.93
Capital Spending - 5 Yr. Growth Rate -4.18 15.13 15.14

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.49 2.55
Current Ratio (MRQ) 0.03 3.50 3.57
LT Debt to Equity (MRQ) 303.32 11.00 13.37
Total Debt to Equity (MRQ) 1,266.49 17.12 19.35
Interest Coverage (TTM) -1.72 49.79 44.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.26 54.91
Gross Margin - 5 Yr. Avg. -- 52.36 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -301,733.31 18.39 15.51
Operating Margin (TTM) -- 14.76 6.68
Operating Margin - 5 Yr. Avg. -343,366.69 14.35 10.99
Pre-Tax Margin (TTM) -- 15.22 7.52
Pre-Tax Margin - 5 Yr. Avg. -459,700.00 14.66 11.40
Net Profit Margin (TTM) -- 11.39 3.74
Net Profit Margin - 5 Yr. Avg. -436,680.91 10.99 7.69
Effective Tax Rate (TTM) -- 24.37 24.27
Effective Tax Rate - 5 Yr. Avg. -- 23.47 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 945,352,167 851,754,569
Net Income/Employee (TTM) -2,929,333 110,567,097 99,535,212
Receivable Turnover (TTM) -- 5.90 6.13
Inventory Turnover (TTM) -- 2.73 3.55
Asset Turnover (TTM) 0.00 0.99 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -97.89 11.87 11.32
Return on Assets - 5 Yr. Avg. -74.56 12.86 12.28
Return on Investment (TTM) -161.15 15.07 14.44
Return on Investment - 5 Yr. Avg. -109.15 16.82 16.08
Return on Equity (TTM) -430.75 16.57 16.05
Return on Equity - 5 Yr. Avg. -477.80 17.83 17.28
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 46.87 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Immune Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 2.01%
# of Holders: 15
Total Shares Held: 352,469
3 Mo. Net Change: -176,262
# New Positions: 1
# Closed Positions: 7
# Increased Positions: 4
# Reduced Positions: 10
# Net Buyers: -6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.